06-30 BXP to Release Second Quarter 2026 Financial Results on July 28, 2026 BU
06-25 BXP Executes 320,000 Square Foot Lease with Boston Dynamics at Reservoir Place BU
06-25 Bxp, Inc. Executes Lease Agreement with Boston Dynamics, Inc. At Reservoir Place CI
06-18 BXP Shares Rise After Scotiabank Upgrade MT
06-18 Evercore ISI Adjusts Price Target on BXP to $62 From $67, Maintains In Line Rating MT
06-18 Scotiabank Upgrades BXP to Sector Outperform From Sector Perform, Adjusts PT to $70 From $65 MT
06-18 Evercore ISI Adjusts Price Target on BXP to $67 From $62, Maintains In Line Rating MT
06-18 BXP Keeps Quarterly Dividend at $0.70 a Share, Payable July 31 to Shareholders of Record on June 30 MT
06-18 Bxp, Inc. Declares Regular Quarterly Cash Dividend for the Period April 1, 2026 to June 30, 2026, Payable on July 31, 2026 CI
06-18 BXP Declares Regular Quarterly Dividend BU
06-16 BXP Says McDermott Will & Schulte Signs Lease at 343 Madison MT
06-16 BXP, Inc. Executes Lease Agreement with McDermott Will & Schulte At 343 Madison Avenue CI
06-16 BXP Executes 150,000 Square Foot Lease with McDermott Will & Schulte at 343 Madison Avenue BU
06-15 Evercore ISI Adjusts Price Target on BXP to $67 From $62, Maintains In Line Rating MT
06-10 BXP Insider Sold Shares Worth $1,732,532, According to a Recent SEC Filing MT
06-09 Goldman Sachs Adjusts Price Target on BXP to $65 From $59, Maintains Neutral Rating MT
06-02 BXP, Inc. Presents at Nareit REITweek: 2026 Investor Conference, Jun-02-2026 10:15 AM
06-01 Wells Fargo Adjusts Price Target on BXP to $77 From $69, Maintains Overweight Rating MT
05-30 BXP Inc on May 27, subsidiary of Boston Properties LP entered into agreement to sell certain property for gross purchase price of $63 million RE
05-28 BXP to Present at Nareit’s 2026 REITweek Investor Conference BU
05-27 Truist Adjusts Price Target on BXP to $64 From $70, Maintains Hold Rating MT
05-20 Bxp Insider Sold Shares Worth $287,186, According to a Recent SEC Filing MT
05-18 Barclays Adjusts Price Target on BXP to $65 From $66, Maintains Overweight Rating MT
05-15 Cantor Fitzgerald Adjusts Price Target on BXP to $70 From $79, Maintains Overweight Rating MT
05-14 UBS Adjusts BXP Price Target to $61 From $66, Maintains Neutral Rating MT
No results match your criteria